Limaprost Powder

Limaprost Powder
Details:
CAS: 74397-12-9
Appearance: White Powder
Molecular Formula: C22H36O5
Molecular Weight: 380.52
Purity: NLT 98.0%
Storage conditions: -20°C.
Solubility: Soluble in DMF.
Customization Service: Negotiable; specification, packaging, and labeling can be customized upon request.
Send Inquiry
Description
Send Inquiry

Limaprost Powder (OP1206) is a synthetic prostaglandin E1 analog. It is a powerful prostaglandin drug with a wide range of biological activities and pharmacological effects. From a chemical structure point of view, it contains a cyclopentyl ring and a longer side chain, in which the cyclopentyl ring contains a hydroxyl group and a ketone group. These functional groups are critical to the pharmacological activity of it, allowing it to bind to and exert its effects on prostaglandin E receptors. It exerts its pharmacological effects mainly through binding to prostaglandin E receptors, especially as an analog of prostaglandin E1, which can simulate the biological effects of prostaglandin E1. Prostaglandin E1 has a variety of physiological functions in the human body, including antiplatelet aggregation, dilating blood vessels, increasing glomerular filtration rate, etc. Limaprost, as an analog, also has similar functions.

In clinical application, it is often used to treat circulatory system diseases such as peripheral arterial disease, Raynaud's disease, and diabetic foot. It helps relieve patients' symptoms and promotes the repair and regeneration of damaged tissues by dilating blood vessels, improving microcirculation, and antiplatelet aggregation. Overall, it is a synthetic prostaglandin E1 analog with a broad range of biological activities and pharmacological effects. Its chemical structure contains a cyclopentyl ring and longer side chains, and it works by binding to prostaglandin E receptors. Clinically, it is often used to treat circulatory system diseases. It works by dilating blood vessels and improving microcirculation, providing patients with effective treatment and symptom relief.

 

Shaanxi Medibridge Biotech Co., Ltd. focuses on the supply of pharmaceutical raw materials and research-use compounds. We support customers with stable quality, clear specification communication, flexible packaging options, and document-related support for different project stages.

 

COA

 

product-796-128

Product Name

CAS Number

Batch Number

Limaprost Powder

74397-12-9

MB2608081175

Manufacturer Date

Analysis Date

Expiry Date

2026/8/08

2026/8/09

2028/8/08

Sample Qty Base

Packing

Test Method

650GS

10GS/bottle

HPLC

 

Item

Standard

Results

Appearance

White Powder

Conform

Odor

Characteristic

Conform

Assay

≥99.0%

99.56%

Particle Size

100% pass 80mesh

Conform

Moisture

<5.0%

Conform

Ash Content

<4.0%

Conform

Solvent Residue

Eur.Pharm

Conform

Total Heavy Metals

<10 ppm

Conform

Arsenic

<1.0 ppm

Conform

Lead

<1.0 ppm

Conform

Mercury

<0.5 ppm

Conform

DDT

<0.2ppm

Conform

E. Coli

Negative

Negative

GMO Status

Complies

GMO Free

Irradiation

Complies

Irradiation Free

Conclusion

The batch conforms to the IN-HOUSE standard

product-764-126

 

Prostaglandin Receptors and Cellular Signaling

 

Limaprost is a prostaglandin E1 analogue. Its receptor activity can be investigated at three levels: receptor binding, intracellular signaling, and functional response. Studies using selective agonists have shown that activating EP2 or EP4 can inhibit platelet aggregation under defined experimental conditions. Human platelet studies also support a role for EP4 in regulating aggregation. These findings identify candidate receptors for Limaprost research.

Concentration–response experiments in cells expressing individual receptor subtypes can compare cAMP responses where appropriate. Receptor blockade or receptor-deficient controls can help attribute the response to a specific subtype.

product-1536-1024

Platelet Activation, Aggregation, and Adhesion

 

product-1536-1024

Early animal studies of Limaprost, then designated OP-1206, examined platelet aggregation and adhesion and reported inhibition of platelet responses associated with ADP and collagen stimulation. Because these agonists initiate different signaling pathways, comparisons should specify the agonist, sample source, and assay conditions.

A mechanistic study can measure aggregation kinetics, platelet activation markers, and intracellular cAMP in parallel. Aggregation traces show the timing and extent of the functional response. Activation markers can help identify which step changes, while cAMP provides an intracellular signaling readout.

Vascular Responses and Regional Blood Flow

 

An early study in dogs reported increased coronary blood flow after intracoronary administration of OP-1206. Under the reported conditions, the investigators observed no change in heart rate, blood pressure, or myocardial oxygen consumption. The study illustrates how regional blood flow can be evaluated alongside systemic hemodynamic and tissue metabolic measurements. Cross-study comparisons should account for species, route of exposure, and sampling time.

Isolated-vessel tension experiments can test whether Limaprost directly changes vascular tone. Comparing vessels with intact endothelium and vessels with the endothelium removed can help assess the endothelial contribution.

product-1536-1024

α- and β-Cyclodextrin Complexation

 

product-1536-1024

Inoue and colleagues used nuclear magnetic resonance (NMR) spectroscopy and degradation kinetics to investigate Limaprost in aqueous systems containing α- and β-cyclodextrin. They proposed a ternary inclusion complex involving Limaprost and both cyclodextrins. In a separate solid-state study, adding β-cyclodextrin improved Limaprost stability under high-humidity conditions in the formulations tested. The solution study characterized molecular interactions, while the solid-state study measured stability in a specific formulation.

A comparative study can examine free Limaprost, each cyclodextrin alone, and both cyclodextrins together, measuring inclusion behavior, total dissolved Limaprost, and degradation products. In cellular assays, the uncomplexed fraction is also relevant. Two preparations with the same total dissolved concentration may provide different amounts of Limaprost available for receptor interaction.

Humidity Sensitivity and Water Mobility

 

A solid-state study compared experimental Limaprost Alfadex formulations at 30 °C and 75% relative humidity. The authors discussed how the molecular mobility of water associated with excipients might influence degradation. Samples with similar total moisture can differ in how strongly that water is associated with the solid matrix. The published results apply to the formulations tested. The humidity response of a bulk powder should be measured directly.

Karl Fischer titration can quantify total water, while dynamic vapor sorption (DVS) can characterize moisture uptake and release. Pairing these measurements with chromatographic assays shows whether changes in moisture coincide with loss of Limaprost or accumulation of degradation products.

product-1536-1024

FAQ

 

What is Limaprost 5 mcg used for?

Limaprost 5 mcg is an oral prostaglandin E1 (PGE1) analogue.

What is the mechanism of action of Limaprost alfadex?

Limaprost is a synthetic analog of prostaglandin E1 (PGE1) that acts primarily as an agonist at prostaglandin E receptors (specifically stimulating EP2 and EP4 receptors).

What is the mechanism of action of alfathromb?

Alfathromb is an oral prostaglandin E1 (PGE1) analogue that works through a dual mechanism to improve peripheral and neural microcirculation.

What are the indications for using Opalmon tablets?

Opalmon (generic name: limaprost alfadex) is an oral prostaglandin E1 analog prescribed for specific vascular and neurological conditions.

If you are looking for a high-quality Limaprost Powder manufacturer with whom you can establish a long-term, stable partnership, then Shaanxi Medibridge Biotech Co., Ltd. would be your best business partner. Don't hesitate to contact us at hi@medibridgeapi.com.

 

 

 

 

Hot Tags: limaprost powder, China limaprost powder manufacturers, suppliers, factory, cobicistat active compound powder, dicyclanil feed additive ingredient, heparin sodium pharmaceutical grade material, picamilon pharmaceutical grade material, rapamycin molecular compound powder, telmisartan micronized powder

Send Inquiry